{"gene":"TNFRSF25","run_date":"2026-06-10T10:51:55","timeline":{"discoveries":[{"year":1996,"finding":"DR3 (TNFRSF25) was identified as a death domain-containing TNF receptor family member that induces both apoptosis and NF-κB activation. Signal transduction is mediated by a complex of intracellular signaling molecules including TRADD, TRAF2, FADD, and FLICE (caspase-8).","method":"Molecular cloning, overexpression in cell lines, co-immunoprecipitation of signaling complex components, functional apoptosis and NF-κB activation assays","journal":"Science","confidence":"High","confidence_rationale":"Tier 2 / Strong — original identification paper with multiple orthogonal methods (Co-IP of signaling complex, functional apoptosis assay, NF-κB reporter), foundational study replicated by subsequent work","pmids":["8875942"],"is_preprint":false},{"year":1997,"finding":"DR3 (LARD) undergoes alternative pre-mRNA splicing generating at least 11 distinct isoforms; the full-length isoform (LARD-1) contains transmembrane and death domains and induces spontaneous apoptosis when expressed in 293T cells, whereas other isoforms encode potentially secreted molecules. Upon T cell activation, a programmed switch in alternative splicing occurs so that the membrane-bound full-length form predominates.","method":"Molecular cloning, cDNA sequencing, overexpression in 293T cells with apoptosis readout, RT-PCR of splicing isoforms in lymphocyte subsets before and after activation","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct functional assay (apoptosis induction by LARD-1 overexpression), multiple splicing isoforms characterized by sequencing, activation-induced splicing switch documented","pmids":["9114039"],"is_preprint":false},{"year":1998,"finding":"Caspase-8 is required for DR3-mediated cell death. In Caspase-8-null fibroblasts, DR3 retains the ability to activate JNK and trigger IκBα phosphorylation/degradation but fails to induce apoptosis, demonstrating that Caspase-8 is a necessary and non-redundant component of DR3-initiated death signaling.","method":"Homozygous targeted gene disruption (Casp8 knockout mice), fibroblast cell death assays, JNK activation assay, IκBα phosphorylation/degradation assay","journal":"Immunity","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean genetic knockout with multiple orthogonal readouts (apoptosis, JNK, IκBα), clear separation of death vs. survival signaling","pmids":["9729047"],"is_preprint":false},{"year":2001,"finding":"DR3 plays a non-redundant role in negative selection of thymocytes. DR3-deficient mice show significantly impaired negative selection and anti-CD3-induced apoptosis, while superantigen-induced negative selection, positive selection, and the pre-TCR checkpoint remain normal.","method":"Genetic knockout (DR3-null mice), thymocyte apoptosis assays, negative selection assays with anti-CD3 and superantigen stimulation, positive selection analysis","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic loss-of-function in vivo with multiple defined phenotypic readouts, demonstrating specificity of the DR3 function","pmids":["11313471"],"is_preprint":false},{"year":2002,"finding":"TL1A (TNFSF15), an endothelial cell-derived TNF-family cytokine, is the ligand for DR3 and for decoy receptor TR6/DcR3. TL1A-DR3 interaction induces NF-κB activation and apoptosis in DR3-expressing cell lines, and TL1A costimulates T cells to increase IL-2 responsiveness and secretion of pro-inflammatory cytokines.","method":"Ligand-receptor binding assays, NF-κB activation reporter assays, apoptosis assays in DR3-expressing cell lines, T cell cytokine secretion assays, TR6-Fc antagonism experiments in vitro and in vivo","journal":"Immunity","confidence":"High","confidence_rationale":"Tier 2 / Strong — identification of cognate ligand with binding assays and functional validation via multiple orthogonal methods; replicated across multiple subsequent studies","pmids":["11911831"],"is_preprint":false},{"year":2003,"finding":"TL1A-DR3 interaction forms a signaling complex containing TRADD, TRAF2, and RIP and activates NF-κB as well as ERK, JNK, and p38 MAPK pathways. DR3-mediated NF-κB activation induces c-IAP2 production, which prevents DR3-mediated apoptosis; inhibition of c-IAP2 by RNA interference sensitizes cells to TL1A-induced apoptosis. FADD and procaspase-8 are absent from the TL1A-induced DR3 signaling complex in TF-1 cells.","method":"Co-immunoprecipitation of DR3 signaling complex, NF-κB reporter assay, MAPK kinase assays, pathway-specific inhibitors, RNA interference of c-IAP2, apoptosis assays in TF-1 cells","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Moderate — reciprocal Co-IP of signaling complex, RNAi functional rescue, multiple pathway inhibitors; single lab with multiple orthogonal methods","pmids":["12882979"],"is_preprint":false},{"year":2005,"finding":"DR3 and TNFR1 activate IL-8 gene transcription through distinct kinase cascades despite both receptors activating TRAF2 and NF-κB: DR3 uses the TAK1/ASK1–MKK4/MKK7–JNK2 axis, whereas TNFR1 uses the ASK1–MKK4–JNK1/JNK2/p38MAPK axis for IL-8 induction.","method":"Overexpression of DR3 and TNFR1 in HEK293 cells, dominant-negative kinase constructs, IL-8 reporter gene assays, TRAF2 and NF-κB pathway dissection","journal":"Experimental cell research","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — defined kinase axis by dominant-negative constructs, single lab, single cell model","pmids":["16324699"],"is_preprint":false},{"year":2006,"finding":"During lymphocyte activation, alternative splicing of DR3 mRNA results in upregulation of the complete transmembrane (tm) form of DR3, which is the form responsible for TL1A-mediated costimulation of memory CD4+/CD45RBlo T cells and IFN-γ secretion.","method":"RT-PCR for DR3 mRNA isoforms in activated lymphocytes from mouse models of intestinal inflammation, in vitro T cell stimulation assays with TL1A, cytokine ELISA","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — RT-PCR isoform analysis plus functional assay, replicated across two animal models, single lab","pmids":["16698931"],"is_preprint":false},{"year":2000,"finding":"TWEAK does not interact with DR3 (WSL-1/TRAMP) in in vitro binding assays; TWEAK binds strongly to cells lacking surface DR3, and DR3-knockout cells retain TWEAK responsiveness, establishing that DR3 is not the major functional receptor for TWEAK.","method":"In vitro binding assay with human and murine TWEAK and DR3, cell binding studies on DR3-negative cells, DR3 knockout mouse-derived cells","journal":"FEBS letters","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — negative result established by direct in vitro binding assay plus genetic KO confirmation; this is a mechanistically informative negative finding","pmids":["11094155"],"is_preprint":false},{"year":2008,"finding":"DR3 is required on T cells for immunopathology, local T cell accumulation, and cytokine production at sites of inflammation in EAE and allergic lung inflammation. DR3 is the receptor responsible for TL1A-induced T cell costimulation; dendritic cells are identified as the likely source of TL1A during T cell activation. DR3 is not required for T cell priming or polarization into Th1/Th2/Th17 subsets.","method":"DR3-deficient mouse generation, EAE and allergic lung inflammation models, flow cytometry of T cell subsets, cytokine measurement, adoptive transfer experiments","journal":"Immunity","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean genetic knockout with multiple disease models and defined cellular and cytokine readouts, replicated findings across two independent T cell subset-dependent disease models","pmids":["18571443"],"is_preprint":false},{"year":2008,"finding":"TNFR25 (DR3) signaling is required for Th2 effector function in Th2-polarized CD4 cells and for co-stimulation of IL-13 production by NKT cells in allergic lung inflammation. Blockade of TL1A (TNFSF15) or expression of a dominant-negative TNFR25 transgene inhibits lung inflammation and Th2 cytokine production in vivo.","method":"Antibody blockade of TL1A in vivo, dominant-negative TNFR25 transgenic mice, adoptive transfer of NKT cells (wild-type vs. DN-TNFR25 transgenic), IL-13 cytokine measurement, bronchoalveolar lavage analysis","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal approaches (antibody blockade, dominant-negative transgene, adoptive transfer) in the same study with defined cellular and cytokine readouts","pmids":["18411341"],"is_preprint":false},{"year":2008,"finding":"TL1A-DR3 signaling promotes proliferation of Th17 cells; TL1A-deficient dendritic cells have reduced capacity to support Th17 differentiation and proliferation. TL1A-deficient mice display decreased clinical severity in EAE, with reduced Th17 differentiation and effector function.","method":"TL1A-deficient mouse generation, EAE model, in vitro Th17 differentiation assays with TL1A−/− dendritic cells, flow cytometry of Th17 populations, cytokine analysis","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic knockout of ligand with multiple orthogonal readouts in vitro and in vivo, identifying DR3-expressing Th17 cells as key targets","pmids":["18411337"],"is_preprint":false},{"year":2010,"finding":"TNFR25 (DR3) signaling via agonistic monoclonal antibody 4C12 induces rapid and selective expansion of pre-existing Foxp3+ Tregs in vivo (up to 30-35% of CD4+ T cells within 4 days). This TNFR25-induced Treg proliferation depends on TCR engagement with MHC class II, IL-2 receptor signaling, and Akt signaling, but not CD80/CD86 co-stimulation or rapamycin.","method":"Agonistic monoclonal antibody treatment in mice (clone 4C12), flow cytometry of Treg populations, pharmacological inhibition of Akt and mTOR (rapamycin), blocking antibodies against CD80/CD86, allergic lung inflammation model","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 2 / Strong — agonistic antibody-mediated receptor activation with multiple defined mechanistic dependencies tested by inhibition, clear in vivo phenotypic readout, replicated by subsequent studies","pmids":["20890040"],"is_preprint":false},{"year":2011,"finding":"TNFRSF25 functions as a costimulatory receptor for CD8+ T cells: TL1A-induced triggering of TNFRSF25 in vivo promotes proliferation and accumulation of antigen-specific CD8+ T cells and their differentiation into CTLs. TNFRSF25 also costimulates memory CD8+ T cell secondary expansion.","method":"Ectopic expression of TL1A on plasmacytomas, in vivo tumor challenge model, OT-I TCR transgenic T cell system, flow cytometry for T cell proliferation and CTL differentiation, in vivo memory CD8+ T cell re-expansion assay","journal":"European journal of immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple in vivo functional readouts, direct TL1A-TNFRSF25 axis manipulation, single lab","pmids":["21688261"],"is_preprint":false},{"year":2013,"finding":"Ligation of TNFRSF25 (DR3) by TL1A leads to recruitment of TRAF2 and TRADD in primary T cells with downstream activation of both NF-κB and the PI3K/Akt signaling axis. These signaling pathways depend on coordinated engagement of the TCR and the IL-2 receptor.","method":"Co-immunoprecipitation of TRAF2 and TRADD with DR3 in primary T cells, NF-κB reporter assay, PI3K/Akt pathway activation assays, blocking of TCR and IL-2 receptor signals","journal":"Immunologic research","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — review reporting experimental findings from the authors' prior work with Co-IP and signaling assays; moderate confidence given review format summarizing prior data","pmids":["24242819"],"is_preprint":false},{"year":2014,"finding":"Atsttrin (a progranulin-derived molecule) directly binds to DR3 (TNFRSF25); the first three cysteine-rich domains (CRDs) in the extracellular portion of DR3 are required for this interaction. Atsttrin inhibits the interaction between DR3 and TL1A and neutralizes TL1A-enhanced osteoclastogenesis in vitro.","method":"Direct binding assay (pulldown/ELISA-based screening), domain-mapping with DR3 truncation mutants, competitive binding assay (DR3-TL1A interaction blocked by Atsttrin), in vitro osteoclastogenesis assay, DSS-induced colitis model","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct binding with domain mapping and functional competition assay, single lab with multiple orthogonal methods","pmids":["24651300"],"is_preprint":false},{"year":2015,"finding":"TL1A promotes generation of IL-9-producing Th9 cells through DR3 in a cell-intrinsic manner; TL1A enhances Th9 differentiation via an IL-2 and STAT5-dependent mechanism, distinct from OX40-mediated Th9 induction (which requires IL-4 and STAT6). Endogenous DR3 signaling on T cells is required for maximal IL-9 production and pathology in allergic lung inflammation.","method":"In vitro Th9 differentiation assays with TL1A and DR3-deficient T cells, STAT5 and STAT6 phosphorylation assays, cytokine blocking experiments, DR3-deficient mouse allergic lung inflammation model, cytokine ELISA","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic loss-of-function (DR3 KO T cells), in vitro mechanistic dissection of STAT5 vs. STAT6 dependency, in vivo disease model; multiple orthogonal methods","pmids":["25786692"],"is_preprint":false},{"year":2017,"finding":"The extracellular region of DR3 directly binds to Galectin-9; Galectin-9 associates with DR3 in Tregs. DR3-induced stimulatory activity (Treg expansion and suppression of autoimmunity) is partially dependent on Galectin-9 in vitro and is lost in Galectin-9-deficient mice in EAE and allergic lung inflammation models.","method":"Direct binding assay (extracellular DR3 region and Galectin-9), co-immunoprecipitation of Galectin-9 with DR3 in Tregs, in vitro Treg stimulation with Galectin-9-/- T cells, in vivo EAE and allergic lung inflammation in Galectin-9-/- mice treated with DR3 agonist","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct binding assay, co-IP in primary Tregs, genetic KO in vivo validation across two disease models; multiple orthogonal methods","pmids":["28877989"],"is_preprint":false},{"year":2017,"finding":"DR3 signaling in osteoclast precursors (CD14+ cells) enhances osteoclast differentiation and bone resorption via TL1A, with increased production of CCL3 and MMP-9. DR3 knockout protects mice against collagen-induced arthritis and associated systemic trabecular bone loss.","method":"DR3 knockout mouse CIA model with micro-CT analysis, in vitro osteoclast differentiation of human CD14+ precursors treated with TL1A, TRAP staining, bone resorption pit assay, CCL3/MMP-9 ELISA","journal":"Bone","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic KO in vivo plus in vitro mechanistic dissection in human primary cells; single lab with orthogonal in vivo/in vitro approaches","pmids":["28062298"],"is_preprint":false},{"year":2019,"finding":"Activation of DR3 signaling by agonistic anti-DR3 antibody increases GM-CSF production from ILC3s through the p38 MAPK pathway, causing accumulation of eosinophils, neutrophils, and CD11b+CD11c+ myeloid cells, and resulting in IL-23-dependent loss of ILC3s from the intestine. Blockade of GM-CSF or IL-23 reverses anti-DR3-driven ILC3 loss.","method":"Agonistic anti-DR3 antibody treatment in mice, flow cytometry of intestinal ILC3s and myeloid cells, GM-CSF ELISA, p38 MAPK inhibitor experiments, GM-CSF and IL-23 neutralization, soluble DR3 (TL1A neutralization) in DSS and anti-CD40 colitis models","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 / Strong — defined DR3→p38 MAPK→GM-CSF→IL-23→ILC3 loss pathway with pharmacological rescue at multiple steps; in vivo disease model validation","pmids":["31358760"],"is_preprint":false},{"year":2020,"finding":"Direct TL1A-DR3 signaling on fibroblasts promotes intestinal fibrosis in vivo. DR3 on fibroblasts is required for fibroblast activation and migration; deletion of DR3 specifically on fibroblasts reduces intestinal fibrosis without affecting clinical disease or inflammation. RNA-sequencing identified Rho signal transduction as a major pathway activated by TL1A in fibroblasts.","method":"T cell transfer colitis model in Rag-/-, Rag-/-Dr3-/-, and Rag-/-Dr3ΔCol1a2 mice; collagen deposition assay; fibroblast activation/migration assays in vitro; RNA-sequencing of TL1A-stimulated fibroblasts; Rho pathway inhibition","journal":"Scientific reports","confidence":"High","confidence_rationale":"Tier 2 / Strong — cell type-specific conditional KO combined with in vitro mechanistic pathway identification by RNA-seq and pharmacological inhibition; multiple orthogonal methods","pmids":["33097818"],"is_preprint":false},{"year":2020,"finding":"DR3 on visceral adipose tissue ILC2s is inducible by IL-33. DR3 engagement activates canonical and/or non-canonical NF-κB pathways in ILC2s, stimulating naïve and co-stimulating IL-33-activated ILC2s. DR3 stimulation of adipose ILC2s ameliorates glucose tolerance and reverses established insulin resistance in a type 2 diabetes model.","method":"Flow cytometry of DR3 expression on murine and human ILC2s, IL-33 induction experiments, NF-κB pathway activation assays (canonical and non-canonical), DR3 agonist treatment in vivo, glucose tolerance and insulin resistance assays","journal":"Nature communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — defined NF-κB pathway activation and in vivo functional outcome; single lab with in vitro and in vivo validation","pmids":["32948777"],"is_preprint":false},{"year":2005,"finding":"Comparative structural modeling predicts that the DR3 (TNFRSF25) extracellular domain comprises four cysteine-rich domains (CRDs), and that a rheumatoid arthritis-linked D158G mutation eliminates two hydrogen bonds in a conserved motif at the end of CRD3, likely destabilizing the ligand-receptor complex.","method":"Comparative homology modeling of DR3 extracellular domain based on known TNF receptor crystal structures, energy minimization, structural analysis of RA-linked mutation sites","journal":"Biochemical and biophysical research communications","confidence":"Low","confidence_rationale":"Tier 4 / Weak — computational modeling only, no experimental structural or mutagenesis validation","pmids":["15694416"],"is_preprint":false},{"year":2006,"finding":"The DR3 gene promoter CpG island is specifically hypermethylated in rheumatoid arthritis synovial cells, and this hypermethylation inhibits DR3 gene transcription and reduces DR3 protein expression, potentially providing resistance to apoptosis in RA synovial cells.","method":"Bisulfite genomic sequencing, methylation-specific PCR, luciferase reporter promoter assay, forced methylation with bacterial Sss I methylase in vitro, Western blotting for DR3 protein","journal":"Arthritis and rheumatism","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct promoter activity assay plus forced methylation experiment with functional readout; mechanistic link from methylation to transcription inhibition established","pmids":["16508942"],"is_preprint":false},{"year":2016,"finding":"DR3 signaling modulates the function of Foxp3+ Tregs; DR3-activated Tregs display an activated/mature phenotype and the CD25+Foxp3+ subpopulation shows stronger in vivo suppressive activity. The functional consequence of DR3 signaling is highly dependent on the activation status of T cells: prophylactic DR3 activation expands recipient Tregs and reduces GVHD severity, while DR3 activation during ongoing GVHD further promotes donor T cell activation.","method":"Agonistic anti-DR3 antibody treatment of donor and recipient mice, allogeneic hematopoietic stem cell transplantation model, flow cytometry immunophenotyping, in vivo suppression assays","journal":"Blood","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo functional readout with defined phenotypic immunophenotyping, demonstrates context-dependence of DR3 signaling; single lab","pmids":["27760760"],"is_preprint":false},{"year":2016,"finding":"DR3 is required for intact TL1A/DR3 signaling in protection against acute intestinal injury: DR3-/- mice show more severe DSS colitis, increased mortality, and compromised maintenance of Foxp3+ Tregs, leading to non-specific upregulation of Th17 effector responses. DR3-/- mice also show defective Salmonella clearance with elevated bacterial load.","method":"DR3-deficient mouse DSS colitis model, TL1A-deficient mouse comparison, Salmonella typhimurium infection, flow cytometry of Treg and Th17 populations, cytokine analysis","journal":"Journal of immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic knockout with multiple disease models and defined cellular mechanisms; single lab","pmids":["27233964"],"is_preprint":false},{"year":2017,"finding":"CD4 Th1 cell expression of both IL-18R and DR3 is required for optimal IFN-γ induction in response to non-cognate (TCR-independent) stimulation during Salmonella infection. T cell-intrinsic MyD88 (a DR3 adapter) is required for efficient bacterial clearance from Salmonella, Chlamydia, and Brucella infections.","method":"Conditional T cell-specific receptor knockout mice, non-cognate Th1 stimulation assay in Salmonella-infected mice, IFN-γ ELISA, MyD88 T cell-specific KO mice infected with multiple intracellular bacteria, bacterial burden quantification","journal":"PLoS pathogens","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic loss-of-function with defined in vivo functional readouts; multiple pathogens tested; single lab","pmids":["28817719"],"is_preprint":false}],"current_model":"TNFRSF25 (DR3) is a death domain-containing TNF receptor superfamily member that, upon binding its cognate ligand TL1A (TNFSF15), recruits a signaling complex of TRADD, TRAF2, RIP, and (in cells competent for apoptosis) FADD/caspase-8, leading to activation of NF-κB, JNK/p38 MAPK, and PI3K/Akt pathways in a context-dependent manner that determines cell fate (apoptosis vs. survival/proliferation); it is constitutively expressed on Foxp3+ Tregs and ILC subsets, is inducibly expressed on conventional T cells, ILC2s, and ILC3s upon activation, and functions as a critical costimulatory receptor that promotes effector T cell (Th1, Th2, Th17, Th9, CTL) accumulation at inflammatory sites, selectively expands Tregs through TCR/MHC II- and IL-2R/Akt-dependent signaling, drives ILC3-mediated GM-CSF production via p38 MAPK to regulate intestinal homeostasis, activates ILC2s via NF-κB, promotes osteoclastogenesis and CCL3/MMP-9 production, and directly signals through DR3 on fibroblasts via Rho GTPase pathways to drive intestinal fibrosis."},"narrative":{"mechanistic_narrative":"TNFRSF25 (DR3) is a death domain-containing TNF receptor superfamily member that couples ligand engagement to a binary cell-fate decision between apoptosis and survival/proliferation [PMID:8875942]. Upon binding its cognate ligand TL1A (TNFSF15), DR3 nucleates an intracellular signaling complex of TRADD, TRAF2, and RIP that drives NF-κB together with ERK, JNK, and p38 MAPK activation [PMID:11911831, PMID:12882979], while in apoptosis-competent settings FADD and caspase-8 are recruited to execute death; caspase-8 is the non-redundant effector of DR3-induced killing, since its loss abolishes apoptosis while leaving JNK and IκBα-dependent NF-κB signaling intact [PMID:9729047]. The death-versus-survival balance is set by NF-κB-induced c-IAP2, which restrains apoptosis [PMID:12882979], and by an activation-coupled alternative-splicing switch that selects the full-length transmembrane receptor required for TL1A responsiveness [PMID:9114039, PMID:16698931]. Beyond molecular wiring, DR3 is a critical costimulatory receptor in adaptive and innate immunity: it mediates thymocyte negative selection [PMID:11313471] and, downstream of dendritic-cell-derived TL1A, promotes effector T cell accumulation and cytokine production at inflammatory sites across Th1, Th2, Th9, Th17, and CD8+ CTL responses without controlling lineage priming or polarization [PMID:18571443, PMID:18411341, PMID:18411337, PMID:21688261, PMID:25786692]. Agonistic DR3 signaling selectively expands Foxp3+ Tregs through TCR/MHC II-, IL-2R-, and Akt-dependent signaling [PMID:20890040, PMID:24242819], an activity partly dependent on the DR3-binding lectin Galectin-9 [PMID:28877989]. In innate and stromal compartments DR3 drives ILC3 GM-CSF production via p38 MAPK [PMID:31358760], activates adipose ILC2s through NF-κB [PMID:32948777], promotes osteoclastogenesis with CCL3/MMP-9 output [PMID:28062298], and signals directly on fibroblasts through Rho-pathway activation to drive intestinal fibrosis [PMID:33097818]. DR3 specifically does not serve as the functional receptor for TWEAK [PMID:11094155]. DR3 promoter hypermethylation silencing its expression is linked to rheumatoid arthritis synovial cells [PMID:16508942].","teleology":[{"year":1996,"claim":"Established DR3 as a death-domain TNF receptor that bifurcates into apoptosis and NF-κB outputs, defining the core signaling problem.","evidence":"Molecular cloning with overexpression, Co-IP of the TRADD/TRAF2/FADD/caspase-8 complex, and functional apoptosis/NF-κB assays","pmids":["8875942"],"confidence":"High","gaps":["Endogenous ligand unidentified at this stage","Physiological cell type and context of signaling unknown"]},{"year":1997,"claim":"Showed that alternative splicing generates multiple isoforms and that an activation-coupled switch selects the membrane-bound apoptosis-competent form, linking receptor availability to lymphocyte state.","evidence":"cDNA cloning/sequencing of isoforms, overexpression apoptosis readout in 293T, RT-PCR of splice forms before/after T cell activation","pmids":["9114039"],"confidence":"High","gaps":["Function of secreted isoforms unresolved","Splicing regulators not identified"]},{"year":1998,"claim":"Genetically separated death from survival signaling by showing caspase-8 is required for DR3-induced apoptosis but dispensable for JNK and NF-κB activation.","evidence":"Casp8-knockout fibroblasts with apoptosis, JNK, and IκBα degradation assays","pmids":["9729047"],"confidence":"High","gaps":["Order of complex assembly not resolved","Determinants selecting death vs. survival in vivo unknown"]},{"year":2000,"claim":"Excluded TWEAK as a DR3 ligand, narrowing the search for the cognate ligand.","evidence":"In vitro binding assays and DR3-knockout cell responsiveness tests","pmids":["11094155"],"confidence":"Medium","gaps":["Negative result; did not identify the true ligand"]},{"year":2002,"claim":"Identified TL1A (TNFSF15) as the DR3 ligand and a decoy receptor TR6/DcR3, connecting an endothelial cytokine to DR3-driven apoptosis, NF-κB, and T cell costimulation.","evidence":"Ligand-receptor binding, NF-κB reporter and apoptosis assays in DR3+ lines, T cell cytokine assays, TR6-Fc antagonism in vitro and in vivo","pmids":["11911831"],"confidence":"High","gaps":["In vivo cellular source of TL1A not defined here","Mechanism balancing apoptosis vs. costimulation unresolved"]},{"year":2003,"claim":"Defined the TL1A-induced DR3 complex (TRADD/TRAF2/RIP) and showed NF-κB-induced c-IAP2 gates apoptosis, explaining context-dependent cell fate.","evidence":"Reciprocal Co-IP, NF-κB reporter, MAPK kinase assays, c-IAP2 RNAi rescue in TF-1 cells","pmids":["12882979"],"confidence":"High","gaps":["FADD/caspase-8 recruitment context-dependent and cell-type-specific","Quantitative threshold of c-IAP2 control unknown"]},{"year":2005,"claim":"Distinguished DR3 from TNFR1 by mapping a unique TAK1/ASK1–MKK4/MKK7–JNK2 axis for IL-8 induction despite shared TRAF2/NF-κB use.","evidence":"Overexpression in HEK293 with dominant-negative kinase constructs and IL-8 reporter assays","pmids":["16324699"],"confidence":"Medium","gaps":["Single cell model and overexpression-based","Endogenous relevance of the kinase axis untested"]},{"year":2005,"claim":"Proposed a four-CRD architecture and modeled how an RA-linked D158G mutation might destabilize ligand binding.","evidence":"Comparative homology modeling and energy minimization (no experimental structure)","pmids":["15694416"],"confidence":"Low","gaps":["Computational only; no structural or mutagenesis validation","Predicted destabilization not experimentally confirmed"]},{"year":2006,"claim":"Confirmed in vivo that activation upregulates the full transmembrane DR3 form mediating TL1A costimulation of memory CD4+ T cells and IFN-γ.","evidence":"RT-PCR isoform analysis in intestinal inflammation models plus TL1A stimulation and cytokine ELISA","pmids":["16698931"],"confidence":"Medium","gaps":["Splicing control machinery unidentified","Single lab"]},{"year":2006,"claim":"Linked DR3 promoter CpG hypermethylation to transcriptional silencing in RA synovial cells, a possible apoptosis-resistance mechanism.","evidence":"Bisulfite sequencing, methylation-specific PCR, luciferase promoter assay, forced Sss I methylation, Western blot","pmids":["16508942"],"confidence":"Medium","gaps":["Causal contribution to RA pathology not established in vivo","Upstream trigger of methylation unknown"]},{"year":2008,"claim":"Established DR3 as the in vivo costimulatory receptor for effector T cell accumulation and cytokine production at inflamed sites, acting downstream of priming/polarization.","evidence":"DR3-deficient mice in EAE and allergic lung inflammation, flow cytometry, cytokine measurement, adoptive transfer","pmids":["18571443","18411341","18411337"],"confidence":"High","gaps":["Molecular link between DR3 signaling and tissue accumulation incomplete","Relative contributions across T cell subsets not fully separated"]},{"year":2010,"claim":"Revealed an agonist-driven Treg expansion function dependent on TCR/MHC II, IL-2R, and Akt, opening DR3 as a Treg-targeting axis.","evidence":"Agonistic mAb 4C12 in mice with Akt/mTOR inhibitors, CD80/86 blockade, allergic lung model","pmids":["20890040"],"confidence":"High","gaps":["Mechanism of Treg selectivity over conventional T cells unresolved","Durability of expanded Tregs not defined"]},{"year":2011,"claim":"Extended DR3 costimulation to CD8+ T cells, driving CTL differentiation and memory re-expansion.","evidence":"Ectopic TL1A on plasmacytomas, OT-I transgenic system, in vivo tumor challenge and memory re-expansion assays","pmids":["21688261"],"confidence":"Medium","gaps":["Single lab","Signaling pathway in CD8+ cells not dissected"]},{"year":2013,"claim":"Defined the primary-T-cell signaling complex (TRADD/TRAF2) coupling DR3 to NF-κB and PI3K/Akt with TCR and IL-2R coordination.","evidence":"Co-IP in primary T cells, NF-κB reporter, PI3K/Akt assays, TCR/IL-2R signal blockade (review of authors' data)","pmids":["24242819"],"confidence":"Medium","gaps":["Review-format summary of prior data","Stoichiometry and kinetics of complex not defined"]},{"year":2014,"claim":"Identified Atsttrin as a DR3 ligand-blocking molecule and mapped the first three CRDs as the binding region, providing an antagonist tool.","evidence":"Binding/domain-mapping with DR3 truncations, competitive TL1A-blocking assay, osteoclastogenesis assay, DSS colitis","pmids":["24651300"],"confidence":"Medium","gaps":["Endogenous physiological relevance of Atsttrin-DR3 axis unclear","Single lab"]},{"year":2015,"claim":"Demonstrated cell-intrinsic DR3-driven Th9 generation via an IL-2/STAT5 pathway distinct from OX40/STAT6, refining subset-specific costimulation.","evidence":"DR3-deficient T cell Th9 differentiation, STAT5/STAT6 phospho assays, cytokine blockade, allergic lung model","pmids":["25786692"],"confidence":"High","gaps":["Integration of DR3 with TCR signal strength for Th9 unclear"]},{"year":2016,"claim":"Established context-dependence of DR3 in transplantation: prophylactic activation expands suppressive Tregs and reduces GVHD, whereas activation during ongoing disease worsens donor T cell activation.","evidence":"Agonistic anti-DR3 in allogeneic HSCT model, immunophenotyping, in vivo suppression assays","pmids":["27760760"],"confidence":"Medium","gaps":["Molecular basis of the timing-dependent switch unresolved","Single lab"]},{"year":2016,"claim":"Showed DR3 maintains intestinal Foxp3+ Tregs and protects against acute colitis and Salmonella, with loss skewing toward Th17.","evidence":"DR3-/- DSS colitis, TL1A-/- comparison, Salmonella infection, Treg/Th17 flow cytometry","pmids":["27233964"],"confidence":"Medium","gaps":["Cell-type-specific requirement not fully separated","Single lab"]},{"year":2017,"claim":"Identified Galectin-9 as a DR3-binding partner partly required for DR3-driven Treg expansion and autoimmunity suppression.","evidence":"Direct binding assay, Co-IP in Tregs, Galectin-9-/- T cells in vitro, Galectin-9-/- mice in EAE and allergic lung models","pmids":["28877989"],"confidence":"High","gaps":["How Galectin-9 modifies DR3 signaling biochemically unknown","Relationship to TL1A binding not fully defined"]},{"year":2017,"claim":"Connected DR3 to bone pathology and innate IFN-γ responses: DR3 enhances osteoclastogenesis (CCL3/MMP-9) in arthritis and, with IL-18R, supports non-cognate Th1 IFN-γ during bacterial infection.","evidence":"DR3-/- CIA with micro-CT, human CD14+ osteoclast assays; conditional T cell receptor KO and MyD88 T cell KO in multiple bacterial infections","pmids":["28062298","28817719"],"confidence":"Medium","gaps":["Direct DR3 signaling pathway in osteoclast precursors not fully dissected","Single labs"]},{"year":2019,"claim":"Defined a DR3→p38 MAPK→GM-CSF→IL-23 axis in ILC3s controlling intestinal myeloid recruitment and ILC3 turnover.","evidence":"Agonistic anti-DR3 in mice, flow cytometry, p38 inhibition, GM-CSF/IL-23 neutralization, colitis models","pmids":["31358760"],"confidence":"High","gaps":["Proximal coupling of DR3 to p38 in ILC3s unmapped"]},{"year":2020,"claim":"Extended DR3 function to innate and stromal cells: NF-κB-dependent ILC2 activation in adipose tissue improving glucose homeostasis, and direct Rho-pathway fibroblast signaling driving intestinal fibrosis.","evidence":"IL-33 induction and NF-κB assays in ILC2s with metabolic readouts; fibroblast-specific Dr3 deletion in colitis, fibroblast migration assays, RNA-seq, Rho inhibition","pmids":["32948777","33097818"],"confidence":"High","gaps":["Biochemical link from DR3 to Rho activation undefined","Translation of metabolic findings to human untested"]},{"year":null,"claim":"How a single receptor's downstream complex composition is selected across cell types to choose among apoptosis, NF-κB, MAPK, PI3K/Akt, and Rho outputs remains unresolved.","evidence":"","pmids":[],"confidence":"Low","gaps":["No experimental structure of DR3 or its signaling complex","Cell-type determinants of complex assembly and output selection unknown","Mechanism of Treg-selective expansion not molecularly defined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[0,4,5]},{"term_id":"GO:0048018","term_label":"receptor ligand activity","supporting_discovery_ids":[4]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[12,9,13]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[1,7]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,4,5,14]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[9,12,19,21]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[0,2,5]}],"complexes":[],"partners":["TNFSF15","TRADD","TRAF2","RIPK1","FADD","CASP8","LGALS9"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q93038","full_name":"Tumor necrosis factor receptor superfamily member 25","aliases":["Apo-3","Apoptosis-inducing receptor AIR","Apoptosis-mediating receptor DR3","Apoptosis-mediating receptor TRAMP","Death receptor 3","Lymphocyte-associated receptor of death","LARD","Protein WSL","Protein WSL-1"],"length_aa":417,"mass_kda":45.4,"function":"Receptor for TNFSF12/APO3L/TWEAK. Interacts directly with the adapter TRADD. Mediates activation of NF-kappa-B and induces apoptosis. May play a role in regulating lymphocyte homeostasis","subcellular_location":"Secreted","url":"https://www.uniprot.org/uniprotkb/Q93038/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/TNFRSF25","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/TNFRSF25","total_profiled":1310},"omim":[{"mim_id":"604052","title":"TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY, MEMBER 15; TNFSF15","url":"https://www.omim.org/entry/604052"},{"mim_id":"603611","title":"TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 10A; TNFRSF10A","url":"https://www.omim.org/entry/603611"},{"mim_id":"603500","title":"TUMOR NECROSIS FACTOR RECEPTOR 1-ASSOCIATED DEATH DOMAIN PROTEIN; TRADD","url":"https://www.omim.org/entry/603500"},{"mim_id":"603366","title":"TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 25; TNFRSF25","url":"https://www.omim.org/entry/603366"},{"mim_id":"602695","title":"TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY, MEMBER 12; TNFSF12","url":"https://www.omim.org/entry/602695"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Plasma membrane","reliability":"Approved"},{"location":"Actin filaments","reliability":"Approved"},{"location":"Focal adhesion sites","reliability":"Approved"},{"location":"Nucleoplasm","reliability":"Additional"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"brain","ntpm":42.2},{"tissue":"lymphoid tissue","ntpm":39.8},{"tissue":"pituitary gland","ntpm":26.7}],"url":"https://www.proteinatlas.org/search/TNFRSF25"},"hgnc":{"alias_symbol":["DR3","TRAMP","WSL-1","LARD","WSL-LR","DDR3","TR3","APO-3"],"prev_symbol":["TNFRSF12"]},"alphafold":{"accession":"Q93038","domains":[{"cath_id":"2.10.50.10","chopping":"41-92","consensus_level":"high","plddt":88.7162,"start":41,"end":92},{"cath_id":"1.10.533.10","chopping":"334-416","consensus_level":"high","plddt":89.6116,"start":334,"end":416}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q93038","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q93038-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q93038-F1-predicted_aligned_error_v6.png","plddt_mean":72.31},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=TNFRSF25","jax_strain_url":"https://www.jax.org/strain/search?query=TNFRSF25"},"sequence":{"accession":"Q93038","fasta_url":"https://rest.uniprot.org/uniprotkb/Q93038.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q93038/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q93038"}},"corpus_meta":[{"pmid":"9729047","id":"PMC_9729047","title":"Targeted disruption of the mouse Caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatally.","date":"1998","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/9729047","citation_count":1006,"is_preprint":false},{"pmid":"8875942","id":"PMC_8875942","title":"Signal transduction by DR3, a death domain-containing receptor related to TNFR-1 and CD95.","date":"1996","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/8875942","citation_count":541,"is_preprint":false},{"pmid":"11911831","id":"PMC_11911831","title":"TL1A is a TNF-like ligand for DR3 and TR6/DcR3 and functions as a T cell costimulator.","date":"2002","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/11911831","citation_count":526,"is_preprint":false},{"pmid":"18411337","id":"PMC_18411337","title":"TL1A-DR3 interaction regulates Th17 cell function and Th17-mediated autoimmune disease.","date":"2008","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/18411337","citation_count":187,"is_preprint":false},{"pmid":"18571443","id":"PMC_18571443","title":"The TNF-family receptor DR3 is essential for diverse T cell-mediated inflammatory diseases.","date":"2008","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/18571443","citation_count":180,"is_preprint":false},{"pmid":"9114039","id":"PMC_9114039","title":"LARD: a new lymphoid-specific death domain containing receptor regulated by alternative pre-mRNA splicing.","date":"1997","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/9114039","citation_count":175,"is_preprint":false},{"pmid":"22179700","id":"PMC_22179700","title":"Structure of the full human RXR/VDR nuclear receptor heterodimer complex with its DR3 target DNA.","date":"2011","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/22179700","citation_count":160,"is_preprint":false},{"pmid":"18411341","id":"PMC_18411341","title":"Essential role of TNF receptor superfamily 25 (TNFRSF25) in the development of allergic lung inflammation.","date":"2008","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/18411341","citation_count":153,"is_preprint":false},{"pmid":"16698931","id":"PMC_16698931","title":"Role of TL1A and its receptor DR3 in two models of chronic murine ileitis.","date":"2006","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/16698931","citation_count":137,"is_preprint":false},{"pmid":"20890040","id":"PMC_20890040","title":"Therapeutic Treg expansion in mice by TNFRSF25 prevents allergic lung inflammation.","date":"2010","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/20890040","citation_count":132,"is_preprint":false},{"pmid":"9662410","id":"PMC_9662410","title":"A male-female bias in type 1 diabetes and linkage to chromosome Xp in MHC HLA-DR3-positive patients.","date":"1998","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/9662410","citation_count":115,"is_preprint":false},{"pmid":"24663492","id":"PMC_24663492","title":"High-lard and high-fish-oil diets differ in their effects on function and dynamic behaviour of rat hepatic mitochondria.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24663492","citation_count":114,"is_preprint":false},{"pmid":"22017439","id":"PMC_22017439","title":"TL1A and DR3, a TNF family ligand-receptor pair that promotes lymphocyte costimulation, mucosal hyperplasia, and autoimmune inflammation.","date":"2011","source":"Immunological reviews","url":"https://pubmed.ncbi.nlm.nih.gov/22017439","citation_count":106,"is_preprint":false},{"pmid":"12882979","id":"PMC_12882979","title":"TL1A-induced NF-kappaB activation and c-IAP2 production prevent DR3-mediated apoptosis in TF-1 cells.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12882979","citation_count":105,"is_preprint":false},{"pmid":"12470639","id":"PMC_12470639","title":"Liganded VDR induces CYP3A4 in small intestinal and colon cancer cells via DR3 and ER6 vitamin D responsive elements.","date":"2002","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/12470639","citation_count":97,"is_preprint":false},{"pmid":"16508942","id":"PMC_16508942","title":"Hypermethylated promoter region of DR3, the death receptor 3 gene, in rheumatoid arthritis synovial cells.","date":"2006","source":"Arthritis and rheumatism","url":"https://pubmed.ncbi.nlm.nih.gov/16508942","citation_count":96,"is_preprint":false},{"pmid":"25786692","id":"PMC_25786692","title":"The TNF-family ligand TL1A and its receptor DR3 promote T cell-mediated allergic immunopathology by enhancing differentiation and pathogenicity of IL-9-producing T cells.","date":"2015","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/25786692","citation_count":96,"is_preprint":false},{"pmid":"30972074","id":"PMC_30972074","title":"TL1A (TNFSF15) and DR3 (TNFRSF25): A Co-stimulatory System of Cytokines With Diverse Functions in Gut Mucosal Immunity.","date":"2019","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/30972074","citation_count":93,"is_preprint":false},{"pmid":"11313471","id":"PMC_11313471","title":"DR3 regulates negative selection during thymocyte development.","date":"2001","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/11313471","citation_count":86,"is_preprint":false},{"pmid":"9490691","id":"PMC_9490691","title":"Haplotype HLA-B8-DR3 confers susceptibility to hepatitis C virus-related mixed cryoglobulinemia.","date":"1998","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/9490691","citation_count":76,"is_preprint":false},{"pmid":"23941773","id":"PMC_23941773","title":"Anti-cancer effect and apoptosis induction of cordycepin through DR3 pathway in the human colonic cancer cell HT-29.","date":"2013","source":"Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association","url":"https://pubmed.ncbi.nlm.nih.gov/23941773","citation_count":73,"is_preprint":false},{"pmid":"8207204","id":"PMC_8207204","title":"HLA-DR3 molecules can bind peptides carrying two alternative specific submotifs.","date":"1994","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/8207204","citation_count":73,"is_preprint":false},{"pmid":"21672030","id":"PMC_21672030","title":"Upregulation and nuclear localization of TNF-like cytokine 1A (TL1A) and its receptors DR3 and DcR3 in psoriatic skin lesions.","date":"2011","source":"Experimental dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/21672030","citation_count":72,"is_preprint":false},{"pmid":"27792915","id":"PMC_27792915","title":"Identification of pork flavour precursors from enzyme-treated lard using Maillard model system assessed by GC-MS and partial least squares regression.","date":"2016","source":"Meat science","url":"https://pubmed.ncbi.nlm.nih.gov/27792915","citation_count":72,"is_preprint":false},{"pmid":"15760679","id":"PMC_15760679","title":"Involvement of TL1A and DR3 in induction of pro-inflammatory cytokines and matrix metalloproteinase-9 in atherogenesis.","date":"2005","source":"Cytokine","url":"https://pubmed.ncbi.nlm.nih.gov/15760679","citation_count":71,"is_preprint":false},{"pmid":"10382586","id":"PMC_10382586","title":"Early expression and high prevalence of islet autoantibodies for DR3/4 heterozygous and DR4/4 homozygous offspring of parents with Type I diabetes: the German BABYDIAB study.","date":"1999","source":"Diabetologia","url":"https://pubmed.ncbi.nlm.nih.gov/10382586","citation_count":70,"is_preprint":false},{"pmid":"6603391","id":"PMC_6603391","title":"HLA-DR3 and DR7 in coeliac disease: immunogenetic and clinical aspects.","date":"1983","source":"Gut","url":"https://pubmed.ncbi.nlm.nih.gov/6603391","citation_count":64,"is_preprint":false},{"pmid":"38972055","id":"PMC_38972055","title":"Quinic acid alleviates high-fat diet-induced neuroinflammation by inhibiting DR3/IKK/NF-κB signaling via gut microbial tryptophan metabolites.","date":"2024","source":"Gut microbes","url":"https://pubmed.ncbi.nlm.nih.gov/38972055","citation_count":63,"is_preprint":false},{"pmid":"24453414","id":"PMC_24453414","title":"The role of TL1A and DR3 in autoimmune and inflammatory diseases.","date":"2013","source":"Mediators of inflammation","url":"https://pubmed.ncbi.nlm.nih.gov/24453414","citation_count":59,"is_preprint":false},{"pmid":"24651300","id":"PMC_24651300","title":"Progranulin-derived Atsttrin directly binds to TNFRSF25 (DR3) and inhibits TNF-like ligand 1A (TL1A) activity.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24651300","citation_count":59,"is_preprint":false},{"pmid":"2413154","id":"PMC_2413154","title":"HLA class II regulation and structure. Analysis with HLA-DR3 and HLA-DP point mutants.","date":"1985","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/2413154","citation_count":58,"is_preprint":false},{"pmid":"21688261","id":"PMC_21688261","title":"Triggering of TNFRSF25 promotes CD8⁺ T-cell responses and anti-tumor immunity.","date":"2011","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/21688261","citation_count":56,"is_preprint":false},{"pmid":"32584596","id":"PMC_32584596","title":"The Role of the TL1A/DR3 Axis in the Activation of Group 2 Innate Lymphoid Cells in Subjects with Eosinophilic Asthma.","date":"2020","source":"American journal of respiratory and critical care medicine","url":"https://pubmed.ncbi.nlm.nih.gov/32584596","citation_count":55,"is_preprint":false},{"pmid":"31358760","id":"PMC_31358760","title":"Activation of DR3 signaling causes loss of ILC3s and exacerbates intestinal inflammation.","date":"2019","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/31358760","citation_count":54,"is_preprint":false},{"pmid":"2933448","id":"PMC_2933448","title":"HLA A1-B8-DR3 and suppressor cell function in first-degree relatives of patients with autoimmune chronic active hepatitis.","date":"1985","source":"Journal of hepatology","url":"https://pubmed.ncbi.nlm.nih.gov/2933448","citation_count":53,"is_preprint":false},{"pmid":"31882115","id":"PMC_31882115","title":"Influence of lard-based diacylglycerol on rheological and physicochemical properties of thermally induced gels of porcine myofibrillar protein at different NaCl concentrations.","date":"2019","source":"Food research international (Ottawa, Ont.)","url":"https://pubmed.ncbi.nlm.nih.gov/31882115","citation_count":52,"is_preprint":false},{"pmid":"28877989","id":"PMC_28877989","title":"Regulatory T Cell-Mediated Suppression of Inflammation Induced by DR3 Signaling Is Dependent on Galectin-9.","date":"2017","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/28877989","citation_count":50,"is_preprint":false},{"pmid":"12542740","id":"PMC_12542740","title":"Common HLA-B8-DR3 haplotype in Northern India is different from that found in Europe.","date":"2002","source":"Tissue antigens","url":"https://pubmed.ncbi.nlm.nih.gov/12542740","citation_count":49,"is_preprint":false},{"pmid":"22847642","id":"PMC_22847642","title":"Differential effects of high-fat-diet rich in lard oil or soybean oil on osteopontin expression and inflammation of adipose tissue in diet-induced obese rats.","date":"2012","source":"European journal of nutrition","url":"https://pubmed.ncbi.nlm.nih.gov/22847642","citation_count":49,"is_preprint":false},{"pmid":"16216463","id":"PMC_16216463","title":"Genotoxicity and oxidative stress of the mutagenic compounds formed in fumes of heated soybean oil, sunflower oil and lard.","date":"2005","source":"Toxicology in vitro : an international journal published in association with BIBRA","url":"https://pubmed.ncbi.nlm.nih.gov/16216463","citation_count":47,"is_preprint":false},{"pmid":"28400577","id":"PMC_28400577","title":"Fish oil, lard and soybean oil differentially shape gut microbiota of middle-aged rats.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28400577","citation_count":47,"is_preprint":false},{"pmid":"11094155","id":"PMC_11094155","title":"Studies on the interaction between TWEAK and the death receptor WSL-1/TRAMP (DR3).","date":"2000","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/11094155","citation_count":46,"is_preprint":false},{"pmid":"26099067","id":"PMC_26099067","title":"Tumor Necrosis Factor-like Cytokine TL1A and Its Receptors DR3 and DcR3: Important New Factors in Mucosal Homeostasis and Inflammation.","date":"2015","source":"Inflammatory bowel diseases","url":"https://pubmed.ncbi.nlm.nih.gov/26099067","citation_count":45,"is_preprint":false},{"pmid":"16929349","id":"PMC_16929349","title":"Conserved extended haplotypes discriminate HLA-DR3-homozygous Basque patients with type 1 diabetes mellitus and celiac disease.","date":"2006","source":"Genes and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/16929349","citation_count":45,"is_preprint":false},{"pmid":"26775153","id":"PMC_26775153","title":"Properties and oxidative stability of emulsions prepared with myofibrillar protein and lard diacylglycerols.","date":"2016","source":"Meat science","url":"https://pubmed.ncbi.nlm.nih.gov/26775153","citation_count":45,"is_preprint":false},{"pmid":"26046454","id":"PMC_26046454","title":"Human group3 innate lymphoid cells express DR3 and respond to TL1A with enhanced IL-22 production and IL-2-dependent proliferation.","date":"2015","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/26046454","citation_count":40,"is_preprint":false},{"pmid":"27760760","id":"PMC_27760760","title":"DR3 signaling modulates the function of Foxp3+ regulatory T cells and the severity of acute graft-versus-host disease.","date":"2016","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/27760760","citation_count":40,"is_preprint":false},{"pmid":"25887448","id":"PMC_25887448","title":"The TL1A/DR3/DcR3 pathway in autoimmune rheumatic diseases.","date":"2015","source":"Seminars in arthritis and rheumatism","url":"https://pubmed.ncbi.nlm.nih.gov/25887448","citation_count":39,"is_preprint":false},{"pmid":"27375435","id":"PMC_27375435","title":"Effects of an High-Fat Diet Enriched in Lard or in Fish Oil on the Hypothalamic Amp-Activated Protein Kinase and Inflammatory Mediators.","date":"2016","source":"Frontiers in cellular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/27375435","citation_count":39,"is_preprint":false},{"pmid":"3009607","id":"PMC_3009607","title":"Altered phagocytosis by monocytes from HLA-DR2 and DR3-positive healthy adults is Fc gamma receptor specific.","date":"1986","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/3009607","citation_count":38,"is_preprint":false},{"pmid":"22902792","id":"PMC_22902792","title":"Tregs expanded in vivo by TNFRSF25 agonists promote cardiac allograft survival.","date":"2012","source":"Transplantation","url":"https://pubmed.ncbi.nlm.nih.gov/22902792","citation_count":37,"is_preprint":false},{"pmid":"27233964","id":"PMC_27233964","title":"A Novel Role for TL1A/DR3 in Protection against Intestinal Injury and Infection.","date":"2016","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/27233964","citation_count":37,"is_preprint":false},{"pmid":"10871191","id":"PMC_10871191","title":"Co-expression of HLA DR3 and DQ8 results in the development of spontaneous insulitis and loss of tolerance to GAD65 in transgenic mice.","date":"2000","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/10871191","citation_count":37,"is_preprint":false},{"pmid":"22496363","id":"PMC_22496363","title":"Changes in glucose tolerance and leptin responsiveness of rats offered a choice of lard, sucrose, and chow.","date":"2012","source":"American journal of physiology. Regulatory, integrative and comparative physiology","url":"https://pubmed.ncbi.nlm.nih.gov/22496363","citation_count":37,"is_preprint":false},{"pmid":"39266053","id":"PMC_39266053","title":"Targeting TL1A and DR3: the new frontier of anti-cytokine therapy in IBD.","date":"2025","source":"Gut","url":"https://pubmed.ncbi.nlm.nih.gov/39266053","citation_count":36,"is_preprint":false},{"pmid":"24242819","id":"PMC_24242819","title":"Immunobiology of TNFSF15 and TNFRSF25.","date":"2013","source":"Immunologic research","url":"https://pubmed.ncbi.nlm.nih.gov/24242819","citation_count":35,"is_preprint":false},{"pmid":"3262691","id":"PMC_3262691","title":"Ro(SS-A) positive Sjogren's/lupus erythematosus (SC/LE) overlap patients are associated with the HLA-DR3 and/or DRw6 phenotypes.","date":"1988","source":"The Journal of investigative dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/3262691","citation_count":35,"is_preprint":false},{"pmid":"27420798","id":"PMC_27420798","title":"Physicochemical and structural properties of composite gels prepared with myofibrillar protein and lard diacylglycerols.","date":"2016","source":"Meat science","url":"https://pubmed.ncbi.nlm.nih.gov/27420798","citation_count":34,"is_preprint":false},{"pmid":"7558912","id":"PMC_7558912","title":"T-cell activation in HLA-B8, DR3-positive individuals. Early antigen expression defect in vitro.","date":"1995","source":"Human immunology","url":"https://pubmed.ncbi.nlm.nih.gov/7558912","citation_count":34,"is_preprint":false},{"pmid":"33097818","id":"PMC_33097818","title":"Direct signaling of TL1A-DR3 on fibroblasts induces intestinal fibrosis in vivo.","date":"2020","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/33097818","citation_count":33,"is_preprint":false},{"pmid":"10674967","id":"PMC_10674967","title":"HLA associations in type 1 diabetes among patients not carrying high-risk DR3-DQ2 or DR4-DQ8 haplotypes.","date":"1999","source":"Tissue antigens","url":"https://pubmed.ncbi.nlm.nih.gov/10674967","citation_count":33,"is_preprint":false},{"pmid":"1541486","id":"PMC_1541486","title":"The evolutionary origin of the HLA-DR3 haplotype.","date":"1992","source":"Immunogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/1541486","citation_count":32,"is_preprint":false},{"pmid":"24223162","id":"PMC_24223162","title":"Differential responses of hepatic endoplasmic reticulum stress and inflammation in diet-induced obese rats with high-fat diet rich in lard oil or soybean oil.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24223162","citation_count":32,"is_preprint":false},{"pmid":"22956587","id":"PMC_22956587","title":"T cell costimulation by TNFR superfamily (TNFRSF)4 and TNFRSF25 in the context of vaccination.","date":"2012","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/22956587","citation_count":30,"is_preprint":false},{"pmid":"32948777","id":"PMC_32948777","title":"DR3 stimulation of adipose resident ILC2s ameliorates type 2 diabetes mellitus.","date":"2020","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/32948777","citation_count":30,"is_preprint":false},{"pmid":"2044237","id":"PMC_2044237","title":"DR3 and nonDR3 associated complement component C4A deficiency in systemic lupus erythematosus.","date":"1991","source":"Clinical immunology and immunopathology","url":"https://pubmed.ncbi.nlm.nih.gov/2044237","citation_count":29,"is_preprint":false},{"pmid":"15241467","id":"PMC_15241467","title":"Death receptor 3 (DR3) gene duplication in a chromosome region 1p36.3: gene duplication is more prevalent in rheumatoid arthritis.","date":"2004","source":"Genes and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/15241467","citation_count":29,"is_preprint":false},{"pmid":"19342694","id":"PMC_19342694","title":"HLA-DQ8 (DQB1*0302)-restricted Th17 cells exacerbate experimental autoimmune encephalomyelitis in HLA-DR3-transgenic mice.","date":"2009","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/19342694","citation_count":29,"is_preprint":false},{"pmid":"28062298","id":"PMC_28062298","title":"CCL3 and MMP-9 are induced by TL1A during death receptor 3 (TNFRSF25)-dependent osteoclast function and systemic bone loss.","date":"2017","source":"Bone","url":"https://pubmed.ncbi.nlm.nih.gov/28062298","citation_count":28,"is_preprint":false},{"pmid":"9615223","id":"PMC_9615223","title":"Duplication of the DR3 gene on human chromosome 1p36 and its deletion in human neuroblastoma.","date":"1998","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/9615223","citation_count":27,"is_preprint":false},{"pmid":"28817719","id":"PMC_28817719","title":"T cell expression of IL-18R and DR3 is essential for non-cognate stimulation of Th1 cells and optimal clearance of intracellular bacteria.","date":"2017","source":"PLoS pathogens","url":"https://pubmed.ncbi.nlm.nih.gov/28817719","citation_count":27,"is_preprint":false},{"pmid":"35665810","id":"PMC_35665810","title":"Intralymphatic GAD-Alum (Diamyd®) Improves Glycemic Control in Type 1 Diabetes With HLA DR3-DQ2.","date":"2022","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/35665810","citation_count":26,"is_preprint":false},{"pmid":"14678262","id":"PMC_14678262","title":"Graves' hyperthyroidism and thyroiditis in HLA-DRB1*0301 (DR3) transgenic mice after immunization with thyrotropin receptor DNA.","date":"2004","source":"Clinical and experimental immunology","url":"https://pubmed.ncbi.nlm.nih.gov/14678262","citation_count":26,"is_preprint":false},{"pmid":"21868195","id":"PMC_21868195","title":"HLA-DR3 restricted T cell epitope mimicry in induction of autoimmune response to lupus-associated antigen SmD.","date":"2011","source":"Journal of autoimmunity","url":"https://pubmed.ncbi.nlm.nih.gov/21868195","citation_count":25,"is_preprint":false},{"pmid":"15926921","id":"PMC_15926921","title":"Hepatic vagotomy alters limbic and hypothalamic neuropeptide responses to insulin-dependent diabetes and voluntary lard ingestion.","date":"2005","source":"The European journal of neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/15926921","citation_count":24,"is_preprint":false},{"pmid":"12941547","id":"PMC_12941547","title":"Heterozygosity for MICA5.0/MICA5.1 and HLA-DR3-DQ2/DR4-DQ8 are independent genetic risk factors for latent autoimmune diabetes in adults.","date":"2003","source":"Human immunology","url":"https://pubmed.ncbi.nlm.nih.gov/12941547","citation_count":24,"is_preprint":false},{"pmid":"22811539","id":"PMC_22811539","title":"TNFRSF25 agonistic antibody and galectin-9 combination therapy controls herpes simplex virus-induced immunoinflammatory lesions.","date":"2012","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/22811539","citation_count":23,"is_preprint":false},{"pmid":"35584813","id":"PMC_35584813","title":"The Lard Works in Mysterious Ways: Ceramides in Nutrition-Linked Chronic Disease.","date":"2022","source":"Annual review of nutrition","url":"https://pubmed.ncbi.nlm.nih.gov/35584813","citation_count":22,"is_preprint":false},{"pmid":"8722074","id":"PMC_8722074","title":"Transcomplementation of HLA DQA1-DQB1 in DR3/DR4 and DR3/DR9 heterozygotes and IDDM in Taiwanese families.","date":"1995","source":"Diabetes care","url":"https://pubmed.ncbi.nlm.nih.gov/8722074","citation_count":22,"is_preprint":false},{"pmid":"31020640","id":"PMC_31020640","title":"Naturally processed HLA-DR3-restricted HHV-6B peptides are recognized broadly with polyfunctional and cytotoxic CD4 T-cell responses.","date":"2019","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/31020640","citation_count":22,"is_preprint":false},{"pmid":"12889995","id":"PMC_12889995","title":"Expression and function of HLA-DR3 and DQ8 in transgenic mice lacking functional H2-M.","date":"2003","source":"Tissue antigens","url":"https://pubmed.ncbi.nlm.nih.gov/12889995","citation_count":21,"is_preprint":false},{"pmid":"6603652","id":"PMC_6603652","title":"HLA-DR3- and HLA-DR7-restricted T-cell hyporesponsiveness to gluten antigen: a clue to the aetiology of coeliac disease?","date":"1983","source":"Scandinavian journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/6603652","citation_count":21,"is_preprint":false},{"pmid":"16324699","id":"PMC_16324699","title":"Differential regulation of interleukin-8 gene transcription by death receptor 3 (DR3) and type I TNF receptor (TNFRI).","date":"2005","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/16324699","citation_count":21,"is_preprint":false},{"pmid":"31450308","id":"PMC_31450308","title":"Ultrasound-mediated interfacial protein adsorption and fat crystallization in cholesterol-reduced lard emulsion.","date":"2019","source":"Ultrasonics sonochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/31450308","citation_count":20,"is_preprint":false},{"pmid":"35255540","id":"PMC_35255540","title":"The TL1A-DR3 Axis in Asthma: Membrane-Bound and Secreted TL1A Co-Determined the Development of Airway Remodeling.","date":"2022","source":"Allergy, asthma & immunology research","url":"https://pubmed.ncbi.nlm.nih.gov/35255540","citation_count":20,"is_preprint":false},{"pmid":"35359966","id":"PMC_35359966","title":"TL1A/DR3 Axis, A Key Target of TNF-a, Augments the Epithelial-Mesenchymal Transformation of Epithelial Cells in OVA-Induced Asthma.","date":"2022","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/35359966","citation_count":20,"is_preprint":false},{"pmid":"31980336","id":"PMC_31980336","title":"Cepharanthine blocks TSH receptor peptide presentation by HLA-DR3: Therapeutic implications to Graves' disease.","date":"2020","source":"Journal of autoimmunity","url":"https://pubmed.ncbi.nlm.nih.gov/31980336","citation_count":20,"is_preprint":false},{"pmid":"12392851","id":"PMC_12392851","title":"Modulation of insulitis and type 1 diabetes by transgenic HLA-DR3 and DQ8 in NOD mice lacking endogenous MHC class II.","date":"2002","source":"Human immunology","url":"https://pubmed.ncbi.nlm.nih.gov/12392851","citation_count":20,"is_preprint":false},{"pmid":"20007529","id":"PMC_20007529","title":"Differential responses to Smith D autoantigen by mice with HLA-DR and HLA-DQ transgenes: dominant responses by HLA-DR3 transgenic mice with diversification of autoantibodies to small nuclear ribonucleoprotein, double-stranded DNA, and nuclear antigens.","date":"2009","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/20007529","citation_count":20,"is_preprint":false},{"pmid":"11884478","id":"PMC_11884478","title":"A 320-kilobase artificial chromosome encoding the human HLA DR3-DQ2 MHC haplotype confers HLA restriction in transgenic mice.","date":"2002","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/11884478","citation_count":20,"is_preprint":false},{"pmid":"31379829","id":"PMC_31379829","title":"Activation of the DR3-TL1A Axis in Donor Mice Leads to Regulatory T Cell Expansion and Activation With Reduction in Graft-Versus-Host Disease.","date":"2019","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/31379829","citation_count":19,"is_preprint":false},{"pmid":"33176505","id":"PMC_33176505","title":"Comparative study of dietary fat: lard and sugar as a better obesity and metabolic syndrome mice model.","date":"2020","source":"Archives of physiology and biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/33176505","citation_count":18,"is_preprint":false},{"pmid":"30962219","id":"PMC_30962219","title":"Genetic Variation Within the HLA-DRA1 Gene Modulates Susceptibility to Type 1 Diabetes in HLA-DR3 Homozygotes.","date":"2019","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/30962219","citation_count":18,"is_preprint":false},{"pmid":"1581772","id":"PMC_1581772","title":"Association of DR3 with susceptibility to and severity of primary Sjögren's syndrome in a family study.","date":"1992","source":"British journal of rheumatology","url":"https://pubmed.ncbi.nlm.nih.gov/1581772","citation_count":18,"is_preprint":false},{"pmid":"30511687","id":"PMC_30511687","title":"Association of HLA-DR3 and HLA-DR15 Polymorphisms with Risk of Systemic Lupus Erythematosus.","date":"2018","source":"Chinese medical journal","url":"https://pubmed.ncbi.nlm.nih.gov/30511687","citation_count":17,"is_preprint":false},{"pmid":"15694416","id":"PMC_15694416","title":"Comparative modeling of TNFRSF25 (DR3) predicts receptor destabilization by a mutation linked to rheumatoid arthritis.","date":"2005","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/15694416","citation_count":17,"is_preprint":false},{"pmid":"35276916","id":"PMC_35276916","title":"A Lard and Soybean Oil Mixture Alleviates Low-Fat-High-Carbohydrate Diet-Induced Nonalcoholic Fatty Liver Disease in Mice.","date":"2022","source":"Nutrients","url":"https://pubmed.ncbi.nlm.nih.gov/35276916","citation_count":17,"is_preprint":false},{"pmid":"35034939","id":"PMC_35034939","title":"Different Effects of Lard and Vegetable Blend Oil on Intestinal Microorganisms, Enzyme Activity and Blood Routine in Mice.","date":"2022","source":"Journal of oleo science","url":"https://pubmed.ncbi.nlm.nih.gov/35034939","citation_count":17,"is_preprint":false},{"pmid":"14611699","id":"PMC_14611699","title":"Thyrotropin receptor-DNA vaccination of transgenic mice expressing HLA-DR3 or HLA-DQ6b.","date":"2003","source":"Thyroid : official journal of the American Thyroid Association","url":"https://pubmed.ncbi.nlm.nih.gov/14611699","citation_count":17,"is_preprint":false},{"pmid":"26810853","id":"PMC_26810853","title":"Biologics beyond TNF-α inhibitors and the effect of targeting the homologues TL1A-DR3 pathway in chronic inflammatory disorders.","date":"2016","source":"Immunopharmacology and immunotoxicology","url":"https://pubmed.ncbi.nlm.nih.gov/26810853","citation_count":17,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":51557,"output_tokens":7624,"usd":0.134516,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":16964,"output_tokens":6131,"usd":0.119048,"stage2_stop_reason":"end_turn"},"total_usd":0.253564,"stage1_batch_id":"msgbatch_017qqVz33Ga63SCDwzb35XPb","stage2_batch_id":"msgbatch_01Scr2Ei9x4HJMiRGxwrmvLK","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1996,\n      \"finding\": \"DR3 (TNFRSF25) was identified as a death domain-containing TNF receptor family member that induces both apoptosis and NF-κB activation. Signal transduction is mediated by a complex of intracellular signaling molecules including TRADD, TRAF2, FADD, and FLICE (caspase-8).\",\n      \"method\": \"Molecular cloning, overexpression in cell lines, co-immunoprecipitation of signaling complex components, functional apoptosis and NF-κB activation assays\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — original identification paper with multiple orthogonal methods (Co-IP of signaling complex, functional apoptosis assay, NF-κB reporter), foundational study replicated by subsequent work\",\n      \"pmids\": [\"8875942\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"DR3 (LARD) undergoes alternative pre-mRNA splicing generating at least 11 distinct isoforms; the full-length isoform (LARD-1) contains transmembrane and death domains and induces spontaneous apoptosis when expressed in 293T cells, whereas other isoforms encode potentially secreted molecules. Upon T cell activation, a programmed switch in alternative splicing occurs so that the membrane-bound full-length form predominates.\",\n      \"method\": \"Molecular cloning, cDNA sequencing, overexpression in 293T cells with apoptosis readout, RT-PCR of splicing isoforms in lymphocyte subsets before and after activation\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct functional assay (apoptosis induction by LARD-1 overexpression), multiple splicing isoforms characterized by sequencing, activation-induced splicing switch documented\",\n      \"pmids\": [\"9114039\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"Caspase-8 is required for DR3-mediated cell death. In Caspase-8-null fibroblasts, DR3 retains the ability to activate JNK and trigger IκBα phosphorylation/degradation but fails to induce apoptosis, demonstrating that Caspase-8 is a necessary and non-redundant component of DR3-initiated death signaling.\",\n      \"method\": \"Homozygous targeted gene disruption (Casp8 knockout mice), fibroblast cell death assays, JNK activation assay, IκBα phosphorylation/degradation assay\",\n      \"journal\": \"Immunity\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean genetic knockout with multiple orthogonal readouts (apoptosis, JNK, IκBα), clear separation of death vs. survival signaling\",\n      \"pmids\": [\"9729047\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"DR3 plays a non-redundant role in negative selection of thymocytes. DR3-deficient mice show significantly impaired negative selection and anti-CD3-induced apoptosis, while superantigen-induced negative selection, positive selection, and the pre-TCR checkpoint remain normal.\",\n      \"method\": \"Genetic knockout (DR3-null mice), thymocyte apoptosis assays, negative selection assays with anti-CD3 and superantigen stimulation, positive selection analysis\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic loss-of-function in vivo with multiple defined phenotypic readouts, demonstrating specificity of the DR3 function\",\n      \"pmids\": [\"11313471\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"TL1A (TNFSF15), an endothelial cell-derived TNF-family cytokine, is the ligand for DR3 and for decoy receptor TR6/DcR3. TL1A-DR3 interaction induces NF-κB activation and apoptosis in DR3-expressing cell lines, and TL1A costimulates T cells to increase IL-2 responsiveness and secretion of pro-inflammatory cytokines.\",\n      \"method\": \"Ligand-receptor binding assays, NF-κB activation reporter assays, apoptosis assays in DR3-expressing cell lines, T cell cytokine secretion assays, TR6-Fc antagonism experiments in vitro and in vivo\",\n      \"journal\": \"Immunity\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — identification of cognate ligand with binding assays and functional validation via multiple orthogonal methods; replicated across multiple subsequent studies\",\n      \"pmids\": [\"11911831\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"TL1A-DR3 interaction forms a signaling complex containing TRADD, TRAF2, and RIP and activates NF-κB as well as ERK, JNK, and p38 MAPK pathways. DR3-mediated NF-κB activation induces c-IAP2 production, which prevents DR3-mediated apoptosis; inhibition of c-IAP2 by RNA interference sensitizes cells to TL1A-induced apoptosis. FADD and procaspase-8 are absent from the TL1A-induced DR3 signaling complex in TF-1 cells.\",\n      \"method\": \"Co-immunoprecipitation of DR3 signaling complex, NF-κB reporter assay, MAPK kinase assays, pathway-specific inhibitors, RNA interference of c-IAP2, apoptosis assays in TF-1 cells\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal Co-IP of signaling complex, RNAi functional rescue, multiple pathway inhibitors; single lab with multiple orthogonal methods\",\n      \"pmids\": [\"12882979\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"DR3 and TNFR1 activate IL-8 gene transcription through distinct kinase cascades despite both receptors activating TRAF2 and NF-κB: DR3 uses the TAK1/ASK1–MKK4/MKK7–JNK2 axis, whereas TNFR1 uses the ASK1–MKK4–JNK1/JNK2/p38MAPK axis for IL-8 induction.\",\n      \"method\": \"Overexpression of DR3 and TNFR1 in HEK293 cells, dominant-negative kinase constructs, IL-8 reporter gene assays, TRAF2 and NF-κB pathway dissection\",\n      \"journal\": \"Experimental cell research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — defined kinase axis by dominant-negative constructs, single lab, single cell model\",\n      \"pmids\": [\"16324699\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"During lymphocyte activation, alternative splicing of DR3 mRNA results in upregulation of the complete transmembrane (tm) form of DR3, which is the form responsible for TL1A-mediated costimulation of memory CD4+/CD45RBlo T cells and IFN-γ secretion.\",\n      \"method\": \"RT-PCR for DR3 mRNA isoforms in activated lymphocytes from mouse models of intestinal inflammation, in vitro T cell stimulation assays with TL1A, cytokine ELISA\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — RT-PCR isoform analysis plus functional assay, replicated across two animal models, single lab\",\n      \"pmids\": [\"16698931\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"TWEAK does not interact with DR3 (WSL-1/TRAMP) in in vitro binding assays; TWEAK binds strongly to cells lacking surface DR3, and DR3-knockout cells retain TWEAK responsiveness, establishing that DR3 is not the major functional receptor for TWEAK.\",\n      \"method\": \"In vitro binding assay with human and murine TWEAK and DR3, cell binding studies on DR3-negative cells, DR3 knockout mouse-derived cells\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — negative result established by direct in vitro binding assay plus genetic KO confirmation; this is a mechanistically informative negative finding\",\n      \"pmids\": [\"11094155\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"DR3 is required on T cells for immunopathology, local T cell accumulation, and cytokine production at sites of inflammation in EAE and allergic lung inflammation. DR3 is the receptor responsible for TL1A-induced T cell costimulation; dendritic cells are identified as the likely source of TL1A during T cell activation. DR3 is not required for T cell priming or polarization into Th1/Th2/Th17 subsets.\",\n      \"method\": \"DR3-deficient mouse generation, EAE and allergic lung inflammation models, flow cytometry of T cell subsets, cytokine measurement, adoptive transfer experiments\",\n      \"journal\": \"Immunity\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean genetic knockout with multiple disease models and defined cellular and cytokine readouts, replicated findings across two independent T cell subset-dependent disease models\",\n      \"pmids\": [\"18571443\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"TNFR25 (DR3) signaling is required for Th2 effector function in Th2-polarized CD4 cells and for co-stimulation of IL-13 production by NKT cells in allergic lung inflammation. Blockade of TL1A (TNFSF15) or expression of a dominant-negative TNFR25 transgene inhibits lung inflammation and Th2 cytokine production in vivo.\",\n      \"method\": \"Antibody blockade of TL1A in vivo, dominant-negative TNFR25 transgenic mice, adoptive transfer of NKT cells (wild-type vs. DN-TNFR25 transgenic), IL-13 cytokine measurement, bronchoalveolar lavage analysis\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal approaches (antibody blockade, dominant-negative transgene, adoptive transfer) in the same study with defined cellular and cytokine readouts\",\n      \"pmids\": [\"18411341\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"TL1A-DR3 signaling promotes proliferation of Th17 cells; TL1A-deficient dendritic cells have reduced capacity to support Th17 differentiation and proliferation. TL1A-deficient mice display decreased clinical severity in EAE, with reduced Th17 differentiation and effector function.\",\n      \"method\": \"TL1A-deficient mouse generation, EAE model, in vitro Th17 differentiation assays with TL1A−/− dendritic cells, flow cytometry of Th17 populations, cytokine analysis\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic knockout of ligand with multiple orthogonal readouts in vitro and in vivo, identifying DR3-expressing Th17 cells as key targets\",\n      \"pmids\": [\"18411337\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"TNFR25 (DR3) signaling via agonistic monoclonal antibody 4C12 induces rapid and selective expansion of pre-existing Foxp3+ Tregs in vivo (up to 30-35% of CD4+ T cells within 4 days). This TNFR25-induced Treg proliferation depends on TCR engagement with MHC class II, IL-2 receptor signaling, and Akt signaling, but not CD80/CD86 co-stimulation or rapamycin.\",\n      \"method\": \"Agonistic monoclonal antibody treatment in mice (clone 4C12), flow cytometry of Treg populations, pharmacological inhibition of Akt and mTOR (rapamycin), blocking antibodies against CD80/CD86, allergic lung inflammation model\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — agonistic antibody-mediated receptor activation with multiple defined mechanistic dependencies tested by inhibition, clear in vivo phenotypic readout, replicated by subsequent studies\",\n      \"pmids\": [\"20890040\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"TNFRSF25 functions as a costimulatory receptor for CD8+ T cells: TL1A-induced triggering of TNFRSF25 in vivo promotes proliferation and accumulation of antigen-specific CD8+ T cells and their differentiation into CTLs. TNFRSF25 also costimulates memory CD8+ T cell secondary expansion.\",\n      \"method\": \"Ectopic expression of TL1A on plasmacytomas, in vivo tumor challenge model, OT-I TCR transgenic T cell system, flow cytometry for T cell proliferation and CTL differentiation, in vivo memory CD8+ T cell re-expansion assay\",\n      \"journal\": \"European journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple in vivo functional readouts, direct TL1A-TNFRSF25 axis manipulation, single lab\",\n      \"pmids\": [\"21688261\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Ligation of TNFRSF25 (DR3) by TL1A leads to recruitment of TRAF2 and TRADD in primary T cells with downstream activation of both NF-κB and the PI3K/Akt signaling axis. These signaling pathways depend on coordinated engagement of the TCR and the IL-2 receptor.\",\n      \"method\": \"Co-immunoprecipitation of TRAF2 and TRADD with DR3 in primary T cells, NF-κB reporter assay, PI3K/Akt pathway activation assays, blocking of TCR and IL-2 receptor signals\",\n      \"journal\": \"Immunologic research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — review reporting experimental findings from the authors' prior work with Co-IP and signaling assays; moderate confidence given review format summarizing prior data\",\n      \"pmids\": [\"24242819\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Atsttrin (a progranulin-derived molecule) directly binds to DR3 (TNFRSF25); the first three cysteine-rich domains (CRDs) in the extracellular portion of DR3 are required for this interaction. Atsttrin inhibits the interaction between DR3 and TL1A and neutralizes TL1A-enhanced osteoclastogenesis in vitro.\",\n      \"method\": \"Direct binding assay (pulldown/ELISA-based screening), domain-mapping with DR3 truncation mutants, competitive binding assay (DR3-TL1A interaction blocked by Atsttrin), in vitro osteoclastogenesis assay, DSS-induced colitis model\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct binding with domain mapping and functional competition assay, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"24651300\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"TL1A promotes generation of IL-9-producing Th9 cells through DR3 in a cell-intrinsic manner; TL1A enhances Th9 differentiation via an IL-2 and STAT5-dependent mechanism, distinct from OX40-mediated Th9 induction (which requires IL-4 and STAT6). Endogenous DR3 signaling on T cells is required for maximal IL-9 production and pathology in allergic lung inflammation.\",\n      \"method\": \"In vitro Th9 differentiation assays with TL1A and DR3-deficient T cells, STAT5 and STAT6 phosphorylation assays, cytokine blocking experiments, DR3-deficient mouse allergic lung inflammation model, cytokine ELISA\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic loss-of-function (DR3 KO T cells), in vitro mechanistic dissection of STAT5 vs. STAT6 dependency, in vivo disease model; multiple orthogonal methods\",\n      \"pmids\": [\"25786692\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"The extracellular region of DR3 directly binds to Galectin-9; Galectin-9 associates with DR3 in Tregs. DR3-induced stimulatory activity (Treg expansion and suppression of autoimmunity) is partially dependent on Galectin-9 in vitro and is lost in Galectin-9-deficient mice in EAE and allergic lung inflammation models.\",\n      \"method\": \"Direct binding assay (extracellular DR3 region and Galectin-9), co-immunoprecipitation of Galectin-9 with DR3 in Tregs, in vitro Treg stimulation with Galectin-9-/- T cells, in vivo EAE and allergic lung inflammation in Galectin-9-/- mice treated with DR3 agonist\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct binding assay, co-IP in primary Tregs, genetic KO in vivo validation across two disease models; multiple orthogonal methods\",\n      \"pmids\": [\"28877989\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"DR3 signaling in osteoclast precursors (CD14+ cells) enhances osteoclast differentiation and bone resorption via TL1A, with increased production of CCL3 and MMP-9. DR3 knockout protects mice against collagen-induced arthritis and associated systemic trabecular bone loss.\",\n      \"method\": \"DR3 knockout mouse CIA model with micro-CT analysis, in vitro osteoclast differentiation of human CD14+ precursors treated with TL1A, TRAP staining, bone resorption pit assay, CCL3/MMP-9 ELISA\",\n      \"journal\": \"Bone\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic KO in vivo plus in vitro mechanistic dissection in human primary cells; single lab with orthogonal in vivo/in vitro approaches\",\n      \"pmids\": [\"28062298\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Activation of DR3 signaling by agonistic anti-DR3 antibody increases GM-CSF production from ILC3s through the p38 MAPK pathway, causing accumulation of eosinophils, neutrophils, and CD11b+CD11c+ myeloid cells, and resulting in IL-23-dependent loss of ILC3s from the intestine. Blockade of GM-CSF or IL-23 reverses anti-DR3-driven ILC3 loss.\",\n      \"method\": \"Agonistic anti-DR3 antibody treatment in mice, flow cytometry of intestinal ILC3s and myeloid cells, GM-CSF ELISA, p38 MAPK inhibitor experiments, GM-CSF and IL-23 neutralization, soluble DR3 (TL1A neutralization) in DSS and anti-CD40 colitis models\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — defined DR3→p38 MAPK→GM-CSF→IL-23→ILC3 loss pathway with pharmacological rescue at multiple steps; in vivo disease model validation\",\n      \"pmids\": [\"31358760\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Direct TL1A-DR3 signaling on fibroblasts promotes intestinal fibrosis in vivo. DR3 on fibroblasts is required for fibroblast activation and migration; deletion of DR3 specifically on fibroblasts reduces intestinal fibrosis without affecting clinical disease or inflammation. RNA-sequencing identified Rho signal transduction as a major pathway activated by TL1A in fibroblasts.\",\n      \"method\": \"T cell transfer colitis model in Rag-/-, Rag-/-Dr3-/-, and Rag-/-Dr3ΔCol1a2 mice; collagen deposition assay; fibroblast activation/migration assays in vitro; RNA-sequencing of TL1A-stimulated fibroblasts; Rho pathway inhibition\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — cell type-specific conditional KO combined with in vitro mechanistic pathway identification by RNA-seq and pharmacological inhibition; multiple orthogonal methods\",\n      \"pmids\": [\"33097818\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"DR3 on visceral adipose tissue ILC2s is inducible by IL-33. DR3 engagement activates canonical and/or non-canonical NF-κB pathways in ILC2s, stimulating naïve and co-stimulating IL-33-activated ILC2s. DR3 stimulation of adipose ILC2s ameliorates glucose tolerance and reverses established insulin resistance in a type 2 diabetes model.\",\n      \"method\": \"Flow cytometry of DR3 expression on murine and human ILC2s, IL-33 induction experiments, NF-κB pathway activation assays (canonical and non-canonical), DR3 agonist treatment in vivo, glucose tolerance and insulin resistance assays\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — defined NF-κB pathway activation and in vivo functional outcome; single lab with in vitro and in vivo validation\",\n      \"pmids\": [\"32948777\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Comparative structural modeling predicts that the DR3 (TNFRSF25) extracellular domain comprises four cysteine-rich domains (CRDs), and that a rheumatoid arthritis-linked D158G mutation eliminates two hydrogen bonds in a conserved motif at the end of CRD3, likely destabilizing the ligand-receptor complex.\",\n      \"method\": \"Comparative homology modeling of DR3 extracellular domain based on known TNF receptor crystal structures, energy minimization, structural analysis of RA-linked mutation sites\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 4 / Weak — computational modeling only, no experimental structural or mutagenesis validation\",\n      \"pmids\": [\"15694416\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"The DR3 gene promoter CpG island is specifically hypermethylated in rheumatoid arthritis synovial cells, and this hypermethylation inhibits DR3 gene transcription and reduces DR3 protein expression, potentially providing resistance to apoptosis in RA synovial cells.\",\n      \"method\": \"Bisulfite genomic sequencing, methylation-specific PCR, luciferase reporter promoter assay, forced methylation with bacterial Sss I methylase in vitro, Western blotting for DR3 protein\",\n      \"journal\": \"Arthritis and rheumatism\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct promoter activity assay plus forced methylation experiment with functional readout; mechanistic link from methylation to transcription inhibition established\",\n      \"pmids\": [\"16508942\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"DR3 signaling modulates the function of Foxp3+ Tregs; DR3-activated Tregs display an activated/mature phenotype and the CD25+Foxp3+ subpopulation shows stronger in vivo suppressive activity. The functional consequence of DR3 signaling is highly dependent on the activation status of T cells: prophylactic DR3 activation expands recipient Tregs and reduces GVHD severity, while DR3 activation during ongoing GVHD further promotes donor T cell activation.\",\n      \"method\": \"Agonistic anti-DR3 antibody treatment of donor and recipient mice, allogeneic hematopoietic stem cell transplantation model, flow cytometry immunophenotyping, in vivo suppression assays\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo functional readout with defined phenotypic immunophenotyping, demonstrates context-dependence of DR3 signaling; single lab\",\n      \"pmids\": [\"27760760\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"DR3 is required for intact TL1A/DR3 signaling in protection against acute intestinal injury: DR3-/- mice show more severe DSS colitis, increased mortality, and compromised maintenance of Foxp3+ Tregs, leading to non-specific upregulation of Th17 effector responses. DR3-/- mice also show defective Salmonella clearance with elevated bacterial load.\",\n      \"method\": \"DR3-deficient mouse DSS colitis model, TL1A-deficient mouse comparison, Salmonella typhimurium infection, flow cytometry of Treg and Th17 populations, cytokine analysis\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic knockout with multiple disease models and defined cellular mechanisms; single lab\",\n      \"pmids\": [\"27233964\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"CD4 Th1 cell expression of both IL-18R and DR3 is required for optimal IFN-γ induction in response to non-cognate (TCR-independent) stimulation during Salmonella infection. T cell-intrinsic MyD88 (a DR3 adapter) is required for efficient bacterial clearance from Salmonella, Chlamydia, and Brucella infections.\",\n      \"method\": \"Conditional T cell-specific receptor knockout mice, non-cognate Th1 stimulation assay in Salmonella-infected mice, IFN-γ ELISA, MyD88 T cell-specific KO mice infected with multiple intracellular bacteria, bacterial burden quantification\",\n      \"journal\": \"PLoS pathogens\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic loss-of-function with defined in vivo functional readouts; multiple pathogens tested; single lab\",\n      \"pmids\": [\"28817719\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"TNFRSF25 (DR3) is a death domain-containing TNF receptor superfamily member that, upon binding its cognate ligand TL1A (TNFSF15), recruits a signaling complex of TRADD, TRAF2, RIP, and (in cells competent for apoptosis) FADD/caspase-8, leading to activation of NF-κB, JNK/p38 MAPK, and PI3K/Akt pathways in a context-dependent manner that determines cell fate (apoptosis vs. survival/proliferation); it is constitutively expressed on Foxp3+ Tregs and ILC subsets, is inducibly expressed on conventional T cells, ILC2s, and ILC3s upon activation, and functions as a critical costimulatory receptor that promotes effector T cell (Th1, Th2, Th17, Th9, CTL) accumulation at inflammatory sites, selectively expands Tregs through TCR/MHC II- and IL-2R/Akt-dependent signaling, drives ILC3-mediated GM-CSF production via p38 MAPK to regulate intestinal homeostasis, activates ILC2s via NF-κB, promotes osteoclastogenesis and CCL3/MMP-9 production, and directly signals through DR3 on fibroblasts via Rho GTPase pathways to drive intestinal fibrosis.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"TNFRSF25 (DR3) is a death domain-containing TNF receptor superfamily member that couples ligand engagement to a binary cell-fate decision between apoptosis and survival/proliferation [#0]. Upon binding its cognate ligand TL1A (TNFSF15), DR3 nucleates an intracellular signaling complex of TRADD, TRAF2, and RIP that drives NF-\\u03baB together with ERK, JNK, and p38 MAPK activation [#4, #5], while in apoptosis-competent settings FADD and caspase-8 are recruited to execute death; caspase-8 is the non-redundant effector of DR3-induced killing, since its loss abolishes apoptosis while leaving JNK and I\\u03baB\\u03b1-dependent NF-\\u03baB signaling intact [#2]. The death-versus-survival balance is set by NF-\\u03baB-induced c-IAP2, which restrains apoptosis [#5], and by an activation-coupled alternative-splicing switch that selects the full-length transmembrane receptor required for TL1A responsiveness [#1, #7]. Beyond molecular wiring, DR3 is a critical costimulatory receptor in adaptive and innate immunity: it mediates thymocyte negative selection [#3] and, downstream of dendritic-cell-derived TL1A, promotes effector T cell accumulation and cytokine production at inflammatory sites across Th1, Th2, Th9, Th17, and CD8+ CTL responses without controlling lineage priming or polarization [#9, #10, #11, #13, #16]. Agonistic DR3 signaling selectively expands Foxp3+ Tregs through TCR/MHC II-, IL-2R-, and Akt-dependent signaling [#12, #14], an activity partly dependent on the DR3-binding lectin Galectin-9 [#17]. In innate and stromal compartments DR3 drives ILC3 GM-CSF production via p38 MAPK [#19], activates adipose ILC2s through NF-\\u03baB [#21], promotes osteoclastogenesis with CCL3/MMP-9 output [#18], and signals directly on fibroblasts through Rho-pathway activation to drive intestinal fibrosis [#20]. DR3 specifically does not serve as the functional receptor for TWEAK [#8]. DR3 promoter hypermethylation silencing its expression is linked to rheumatoid arthritis synovial cells [#23].\",\n  \"teleology\": [\n    {\n      \"year\": 1996,\n      \"claim\": \"Established DR3 as a death-domain TNF receptor that bifurcates into apoptosis and NF-\\u03baB outputs, defining the core signaling problem.\",\n      \"evidence\": \"Molecular cloning with overexpression, Co-IP of the TRADD/TRAF2/FADD/caspase-8 complex, and functional apoptosis/NF-\\u03baB assays\",\n      \"pmids\": [\"8875942\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Endogenous ligand unidentified at this stage\", \"Physiological cell type and context of signaling unknown\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Showed that alternative splicing generates multiple isoforms and that an activation-coupled switch selects the membrane-bound apoptosis-competent form, linking receptor availability to lymphocyte state.\",\n      \"evidence\": \"cDNA cloning/sequencing of isoforms, overexpression apoptosis readout in 293T, RT-PCR of splice forms before/after T cell activation\",\n      \"pmids\": [\"9114039\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Function of secreted isoforms unresolved\", \"Splicing regulators not identified\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Genetically separated death from survival signaling by showing caspase-8 is required for DR3-induced apoptosis but dispensable for JNK and NF-\\u03baB activation.\",\n      \"evidence\": \"Casp8-knockout fibroblasts with apoptosis, JNK, and I\\u03baB\\u03b1 degradation assays\",\n      \"pmids\": [\"9729047\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Order of complex assembly not resolved\", \"Determinants selecting death vs. survival in vivo unknown\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Excluded TWEAK as a DR3 ligand, narrowing the search for the cognate ligand.\",\n      \"evidence\": \"In vitro binding assays and DR3-knockout cell responsiveness tests\",\n      \"pmids\": [\"11094155\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Negative result; did not identify the true ligand\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Identified TL1A (TNFSF15) as the DR3 ligand and a decoy receptor TR6/DcR3, connecting an endothelial cytokine to DR3-driven apoptosis, NF-\\u03baB, and T cell costimulation.\",\n      \"evidence\": \"Ligand-receptor binding, NF-\\u03baB reporter and apoptosis assays in DR3+ lines, T cell cytokine assays, TR6-Fc antagonism in vitro and in vivo\",\n      \"pmids\": [\"11911831\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo cellular source of TL1A not defined here\", \"Mechanism balancing apoptosis vs. costimulation unresolved\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Defined the TL1A-induced DR3 complex (TRADD/TRAF2/RIP) and showed NF-\\u03baB-induced c-IAP2 gates apoptosis, explaining context-dependent cell fate.\",\n      \"evidence\": \"Reciprocal Co-IP, NF-\\u03baB reporter, MAPK kinase assays, c-IAP2 RNAi rescue in TF-1 cells\",\n      \"pmids\": [\"12882979\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"FADD/caspase-8 recruitment context-dependent and cell-type-specific\", \"Quantitative threshold of c-IAP2 control unknown\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Distinguished DR3 from TNFR1 by mapping a unique TAK1/ASK1\\u2013MKK4/MKK7\\u2013JNK2 axis for IL-8 induction despite shared TRAF2/NF-\\u03baB use.\",\n      \"evidence\": \"Overexpression in HEK293 with dominant-negative kinase constructs and IL-8 reporter assays\",\n      \"pmids\": [\"16324699\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single cell model and overexpression-based\", \"Endogenous relevance of the kinase axis untested\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Proposed a four-CRD architecture and modeled how an RA-linked D158G mutation might destabilize ligand binding.\",\n      \"evidence\": \"Comparative homology modeling and energy minimization (no experimental structure)\",\n      \"pmids\": [\"15694416\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Computational only; no structural or mutagenesis validation\", \"Predicted destabilization not experimentally confirmed\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Confirmed in vivo that activation upregulates the full transmembrane DR3 form mediating TL1A costimulation of memory CD4+ T cells and IFN-\\u03b3.\",\n      \"evidence\": \"RT-PCR isoform analysis in intestinal inflammation models plus TL1A stimulation and cytokine ELISA\",\n      \"pmids\": [\"16698931\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Splicing control machinery unidentified\", \"Single lab\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Linked DR3 promoter CpG hypermethylation to transcriptional silencing in RA synovial cells, a possible apoptosis-resistance mechanism.\",\n      \"evidence\": \"Bisulfite sequencing, methylation-specific PCR, luciferase promoter assay, forced Sss I methylation, Western blot\",\n      \"pmids\": [\"16508942\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Causal contribution to RA pathology not established in vivo\", \"Upstream trigger of methylation unknown\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Established DR3 as the in vivo costimulatory receptor for effector T cell accumulation and cytokine production at inflamed sites, acting downstream of priming/polarization.\",\n      \"evidence\": \"DR3-deficient mice in EAE and allergic lung inflammation, flow cytometry, cytokine measurement, adoptive transfer\",\n      \"pmids\": [\"18571443\", \"18411341\", \"18411337\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular link between DR3 signaling and tissue accumulation incomplete\", \"Relative contributions across T cell subsets not fully separated\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Revealed an agonist-driven Treg expansion function dependent on TCR/MHC II, IL-2R, and Akt, opening DR3 as a Treg-targeting axis.\",\n      \"evidence\": \"Agonistic mAb 4C12 in mice with Akt/mTOR inhibitors, CD80/86 blockade, allergic lung model\",\n      \"pmids\": [\"20890040\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of Treg selectivity over conventional T cells unresolved\", \"Durability of expanded Tregs not defined\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Extended DR3 costimulation to CD8+ T cells, driving CTL differentiation and memory re-expansion.\",\n      \"evidence\": \"Ectopic TL1A on plasmacytomas, OT-I transgenic system, in vivo tumor challenge and memory re-expansion assays\",\n      \"pmids\": [\"21688261\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab\", \"Signaling pathway in CD8+ cells not dissected\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Defined the primary-T-cell signaling complex (TRADD/TRAF2) coupling DR3 to NF-\\u03baB and PI3K/Akt with TCR and IL-2R coordination.\",\n      \"evidence\": \"Co-IP in primary T cells, NF-\\u03baB reporter, PI3K/Akt assays, TCR/IL-2R signal blockade (review of authors' data)\",\n      \"pmids\": [\"24242819\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Review-format summary of prior data\", \"Stoichiometry and kinetics of complex not defined\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Identified Atsttrin as a DR3 ligand-blocking molecule and mapped the first three CRDs as the binding region, providing an antagonist tool.\",\n      \"evidence\": \"Binding/domain-mapping with DR3 truncations, competitive TL1A-blocking assay, osteoclastogenesis assay, DSS colitis\",\n      \"pmids\": [\"24651300\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Endogenous physiological relevance of Atsttrin-DR3 axis unclear\", \"Single lab\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Demonstrated cell-intrinsic DR3-driven Th9 generation via an IL-2/STAT5 pathway distinct from OX40/STAT6, refining subset-specific costimulation.\",\n      \"evidence\": \"DR3-deficient T cell Th9 differentiation, STAT5/STAT6 phospho assays, cytokine blockade, allergic lung model\",\n      \"pmids\": [\"25786692\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Integration of DR3 with TCR signal strength for Th9 unclear\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Established context-dependence of DR3 in transplantation: prophylactic activation expands suppressive Tregs and reduces GVHD, whereas activation during ongoing disease worsens donor T cell activation.\",\n      \"evidence\": \"Agonistic anti-DR3 in allogeneic HSCT model, immunophenotyping, in vivo suppression assays\",\n      \"pmids\": [\"27760760\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular basis of the timing-dependent switch unresolved\", \"Single lab\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Showed DR3 maintains intestinal Foxp3+ Tregs and protects against acute colitis and Salmonella, with loss skewing toward Th17.\",\n      \"evidence\": \"DR3-/- DSS colitis, TL1A-/- comparison, Salmonella infection, Treg/Th17 flow cytometry\",\n      \"pmids\": [\"27233964\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Cell-type-specific requirement not fully separated\", \"Single lab\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Identified Galectin-9 as a DR3-binding partner partly required for DR3-driven Treg expansion and autoimmunity suppression.\",\n      \"evidence\": \"Direct binding assay, Co-IP in Tregs, Galectin-9-/- T cells in vitro, Galectin-9-/- mice in EAE and allergic lung models\",\n      \"pmids\": [\"28877989\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How Galectin-9 modifies DR3 signaling biochemically unknown\", \"Relationship to TL1A binding not fully defined\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Connected DR3 to bone pathology and innate IFN-\\u03b3 responses: DR3 enhances osteoclastogenesis (CCL3/MMP-9) in arthritis and, with IL-18R, supports non-cognate Th1 IFN-\\u03b3 during bacterial infection.\",\n      \"evidence\": \"DR3-/- CIA with micro-CT, human CD14+ osteoclast assays; conditional T cell receptor KO and MyD88 T cell KO in multiple bacterial infections\",\n      \"pmids\": [\"28062298\", \"28817719\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct DR3 signaling pathway in osteoclast precursors not fully dissected\", \"Single labs\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Defined a DR3\\u2192p38 MAPK\\u2192GM-CSF\\u2192IL-23 axis in ILC3s controlling intestinal myeloid recruitment and ILC3 turnover.\",\n      \"evidence\": \"Agonistic anti-DR3 in mice, flow cytometry, p38 inhibition, GM-CSF/IL-23 neutralization, colitis models\",\n      \"pmids\": [\"31358760\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Proximal coupling of DR3 to p38 in ILC3s unmapped\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Extended DR3 function to innate and stromal cells: NF-\\u03baB-dependent ILC2 activation in adipose tissue improving glucose homeostasis, and direct Rho-pathway fibroblast signaling driving intestinal fibrosis.\",\n      \"evidence\": \"IL-33 induction and NF-\\u03baB assays in ILC2s with metabolic readouts; fibroblast-specific Dr3 deletion in colitis, fibroblast migration assays, RNA-seq, Rho inhibition\",\n      \"pmids\": [\"32948777\", \"33097818\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Biochemical link from DR3 to Rho activation undefined\", \"Translation of metabolic findings to human untested\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How a single receptor's downstream complex composition is selected across cell types to choose among apoptosis, NF-\\u03baB, MAPK, PI3K/Akt, and Rho outputs remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No experimental structure of DR3 or its signaling complex\", \"Cell-type determinants of complex assembly and output selection unknown\", \"Mechanism of Treg-selective expansion not molecularly defined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [0, 4, 5]},\n      {\"term_id\": \"GO:0048018\", \"supporting_discovery_ids\": [4]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [12, 9, 13]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [1, 7]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 4, 5, 14]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [9, 12, 19, 21]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [0, 2, 5]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"TNFSF15\", \"TRADD\", \"TRAF2\", \"RIPK1\", \"FADD\", \"CASP8\", \"LGALS9\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":8,"faith_pct":87.5}}